Vue.component('mtpr-overview', { template: '
The percentage of medication therapy interventions that resolve medication therapy problems among individuals participating in a Medication Therapy Management (MTM) program.
' + 'A higher rate indicates better performance.
' + 'Intended Use
' + 'Monitoring measure for MTM programs.
' + 'Data Sources
' + 'MTM program encounter data captured using SNOMED CT and RxNORM codes.
' + 'Denominator
' + 'Medication therapy interventions (MTIs) among individuals participating in an MTM program during the measurement year
' + 'Exclusions
' + 'None.
' + 'Numerator
' + 'MTIs from the denominator that were performed, and therefore resolved the corresponding MTP within 60 days from the date of the MTI.
' + '' +
'Medication Therapy Management (MTM) services are intended to optimize medication use to improve therapeutic outcomes and reduce the risk of adverse medication events. The optimization of medication use is accomplished by following a consistent patient care process.' +
'
' +
'Several studies have assessed the impact of MTM services in disease-specific as well as overall patient outcomes. A study that evaluated clinical, economic and humanistic outcomes over 10 years of MTM services found that of 12,851 medical conditions in 4,849 patients, 7,068 conditions (55%) improved during the course of MTM services.' +
'
' +
'Furthermore, a retrospective study of Medicare Part D beneficiaries found that comprehensive medication reviews (CMRs) are most effective when they address pre-identified MTPs. When used in patients with preidentified MTPs, CMR completion was associated with a significant reduction in acute inpatient admissions (36.8 fewer admissions per 1,000 patients, 95% CI 25-49).' +
'
' +
'In 2014, the Agency for Healthcare Research and Quality (AHRQ) funded a meta-analysis to determine the effectiveness of MTM interventions in the outpatient settings.' +
'
' +
"Although there is evidence demonstrating the clinical impact of MTM services, the lack of standardized documentation has been a barrier to developing meaningful quality measures. To address this need, the Pharmacy Quality Alliance's (PQA's) Measure Development Team 9 created the " +
'PQA MTP Categories Framework' +
'
' +
'To further promote standardized documentation, the MTP categories, medication therapy interventions, and the status of the interventions—to indicate MTP resolution—are cross-walked to Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) codes. Also, the Centers for Medicare & Medicaid Services has encouraged Part D plan sponsors to develop the capacity to collect and report MTPs using a standard framework and common terminology to document MTPs at the beneficiary-level using standard categories and definitions.' +
'
' + 'As the purpose of this measure is to promote standardized documentation and reporting of medication therapy interventions by health plan MTM programs, this measure should only be used for monitoring or surveillance purposes and not for accountability programs (e.g., public reporting, benchmarking, external comparisons, performance payments). Moreover, this measure and the MTP Categories Framework may serve as foundational work for the development of additional MTM measures to assess clinical outcomes and quality of care. Ultimately, the use of this measure may be combined with other data for evaluation of the overall effectiveness of MTM programs.' + '
' + 'The documentation that the MTP has been resolved can be based upon communication from the patient or the doctor. The measure does not require validation via administrative claims data.